	Comprehensive assessment of lower limb edema and its association with quality of life among men with prostate cancer. Support Care Cancer Jensen S, Røder A, Hayes S, Larsen GS, Fode M, Østergren PB, Al-Hamadani MMN, Johansen C, Rafn BS. PMID: 40518468 [PubMed - indexed for MEDLINE]
	Stereotactic Body Radiation Therapy for Primary Renal Cancer and Genetic Markers of Response: A Phase 2 Trial. Eur Urol Oncol Song C, Sung CO, Kim D, Kim Y, Ahn H, Kim MH, Kim JK, Cho YM, Kim YJ, Kim YS. PMID: 40518369 [PubMed - as supplied by publisher]
	Comment on "Assessing the Diagnostic Metrics of Cutaneous Leiomyomas in Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Syndrome: an Observational Study". J Am Acad Dermatol Qi M, Wang W, Xie Y, Li Y, Yang X. PMID: 40518119 [PubMed - as supplied by publisher]
	Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial. Lancet Oncol Tree AC, Hinder V, Chan A, Tolan S, Ostler P, van der Voet H, Kancherla K, Loblaw A, Naismith O, Jain S, Martin A, Price D, Brand D, Chu W, Duffton A, Kelly P, O'Neill B, Staffurth J, Sasso G, Pugh J, Manning G, Brown S, Burnett S, Griffin C, Hall E, van As N, PACE Investigators. PMID: 40517778 [PubMed - as supplied by publisher]
	Node-RADS 1.0 for lymph node involvement detection in renal cell carcinoma: A study on 2D and 3D CT imaging. Eur J Radiol He C, Yuan E, Ye L, Xu H, Wu Q, Yao J, Chen Y, Song B. PMID: 40517517 [PubMed - as supplied by publisher]
	Evaluation of [18F]PSMA-1007 uptake variability in patients with prostate cancer. Clin Physiol Funct Imaging Trägårdh E, Larsson M, Minarik D, Enqvist O, Edenbrandt L. PMID: 40517368 [PubMed - indexed for MEDLINE]
	Identification of CWH43 as a novel prognostic biomarker and therapeutic target in clear cell renal cell carcinoma by a multi-omics approach and correlation with autophagy progression. Discov Oncol Wu A, Bai P, Qu H, Zhang T. PMID: 40517334 [PubMed]
	Smoking and bladder cancer: insights into pathogenesis and public health implications from a bibliometric analysis (1999-2023). Subst Abuse Treat Prev Policy Wang Y, Zhou H, Tang Z, He Z, Zhuo H, Huang Y, Kong J. PMID: 40517257 [PubMed - indexed for MEDLINE]
	Increased cancer risk in kidney transplant patients in Scotland: a national registry linkage study. Br J Cancer Nimmo A, Elyan B, Lakey J, Marjoribanks S, Methven S, Morrison D, Bell S. PMID: 40517146 [PubMed - as supplied by publisher]
	Biological and Clinical Insight into the Prevention and Management of Metastatic Renal Cell Carcinoma with a Sarcomatoid Component. Eur Urol Focus Salgia NJ, Fujiwara Y, Xu B, George S, Muhitch JB, Kauffman EC. PMID: 40517094 [PubMed - as supplied by publisher]
	Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial. Eur Urol Oncol Connor MJ, Shah TT, Sukumar J, Basak D, Fiorentino F, Heath C, Horan G, Johnson N, Khoo V, Khoubehi B, Klimowska-Nassar N, Mangar S, McGrath J, Nohpal de la Rosa C, Price D, Rai B, Sarwar N, Smith A, Staffurth JN, Tam H, Thippu Jayaprakash K, Winkler M, Dudderidge T, Ahmed HU, IP2-ATLANTA Trial Investigators. PMID: 40517058 [PubMed - as supplied by publisher]
	Optimizing Radiation Therapy for Localized Prostate Cancer: Exploring Synergies With Androgen Deprivation Therapy and Novel Systemic Agents. Semin Radiat Oncol Patel KR, Abel M, Basourakos SP, Citrin DE, Madan RA. PMID: 40516982 [PubMed - indexed for MEDLINE]
	Radiopharmaceuticals in Prostate Cancer: General Considerations and Utility in Combination With EBRT. Semin Radiat Oncol Civan C, Guberina N, Krafft U, Fendler WP, Stuschke M, Herrmann K. PMID: 40516981 [PubMed - indexed for MEDLINE]
	The Evolving Management of Radiorecurrent Prostate Cancer. Semin Radiat Oncol Pozin J, Bhandari M, Valle L, Nickols NG, Kishan AU, Kamran SC, Baumann B, Efstathiou JA, Crook J, Pasquier D, Liauw SL, Harkenrider MM, Solanki AA. PMID: 40516980 [PubMed - indexed for MEDLINE]
	Postoperative Radiation Therapy and Controversies Regarding Hormonal Therapy in the Management of Prostate Cancer. Semin Radiat Oncol Achard V, Pra AD, Sargos P. PMID: 40516979 [PubMed - indexed for MEDLINE]
	Debate 3: Oligometastatic Hormone Sensitive Prostate Cancer Management: Systemic Therapy Approach. Semin Radiat Oncol von Amsberg G, Kaune M, Coym A, Strewinsky N, Falkenbach F, Hohenhorst JL, Tilki D, Dyshlovoy S. PMID: 40516978 [PubMed - indexed for MEDLINE]
	Debate 3: Metastasis Directed Therapy in Oligometastatic Prostate Cancer. Semin Radiat Oncol Singh M, Murthy V, Ost P. PMID: 40516977 [PubMed - indexed for MEDLINE]
	Debate 2: The Case for Focal External Beam Radiation Therapy Boost Over Brachytherapy Boost for Prostate Cancer. Semin Radiat Oncol Dornisch AM, Seibert TM. PMID: 40516976 [PubMed - indexed for MEDLINE]
	Debate 2: Primary Localized Prostate Cancer: The Case for Whole-Gland Brachytherapy Boost. Semin Radiat Oncol Chowdhury AA, Hoskin PJ. PMID: 40516975 [PubMed - indexed for MEDLINE]
	Debate 1: High-Risk Localized Prostate Cancer: Why Combination Hormone Therapy and Radiotherapy is the Optimal Treatment Strategy for Most Men. Semin Radiat Oncol Rooney MK, El Kouzi Z, Kouzy R, Mohamad O, Hoffman KE. PMID: 40516974 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 168121

Page 1 of 8407



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy